SPOT Q1 2026 Earnings EPS Beats Estimates by 1445 as Stock Surges 611 Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones RWTN Q1 2026 Earnings EPS Miss Pared by Positive Surprise but Stock Gains Amid Broader Sector Optimism FBP Q1 2026 Earnings EPS Surpasses Estimates by Nearly 10 APPS Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction GRI Bio Inc Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Company Faces Headwinds